Home » TheraSolve Receives Patent for MemoPatch
TheraSolve Receives Patent for MemoPatch
Medical technology and adherence company TheraSolve has received a patent from the United States Patent and Trademark Office for its MemoPatch reminder technology.
MemoPatch is a self-adhesive dermal patch that gives patients a stimulus on the skin when it is time to take a next dose of medication.
The objective of the patch is to help patients successfully adhere to their medication regimens over a longer period of time.
The device is patent protected in the U.S., EU, Japan, China and India. — Michael Cipriano
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May